Mon Jan 06 21:11:50 IST 2025: ## Misinformation Fuels Unnecessary Panic Over Human Metapneumovirus (HMPV) in India
**Chennai, India – January 6, 2025** – A recent surge in sensational media reports claiming a “new dangerous virus” – Human Metapneumovirus (HMPV) – originating from China and spreading across India has caused widespread public confusion and anxiety. However, leading infectious disease specialists are refuting these claims, stating that HMPV is not a new virus and has circulated in India for years.
The misinformation campaign, which has even reached some healthcare professionals, is largely attributed to the recent availability of expensive PCR tests capable of detecting multiple viruses, including HMPV. Previously undetected cases are now being identified, leading to the false impression of a novel outbreak. Many news reports lacked expert input, further raising concerns about the credibility of the information being disseminated.
Dr. Abdul Ghafur, a senior consultant in Infectious Diseases at Apollo Hospital, Chennai, emphasizes that HMPV typically causes mild, self-limiting respiratory infections, primarily affecting vulnerable populations such as the elderly, young children, and immunocompromised individuals. While it can cause severe illness in these groups, the virus itself is not new and does not require widespread panic. The ability to detect HMPV helps doctors avoid unnecessary antibiotic and antiviral use, improving patient care and infection control.
Dr. Ghafur points out that the current media frenzy is diverting resources and attention away from viruses like influenza and RSV, for which vaccines and antivirals are readily available. He calls for responsible journalism, urging media outlets to consult with experts before publishing potentially alarming reports. He also suggests that the Indian Health Ministry should take a more proactive role in combating misinformation, potentially by issuing guidelines for media reporting on public health issues.
The situation highlights a potential economic incentive behind the hype, with some speculating that increased demand for expensive diagnostic tests is driving the narrative. Dr. Ghafur advocates for supporting Indian start-ups developing affordable HMPV PCR tests to improve accessibility and enhance disease surveillance.
The article concludes by stressing the need for vigilance, not panic, along with evidence-based reporting, and continuous professional development through reliable sources for healthcare workers. Public awareness campaigns should focus on a balanced understanding of respiratory viruses, emphasizing prevention and appropriate treatment strategies for vulnerable populations. The HMPV episode serves as a critical reminder of the importance of accurate, fact-based reporting and the crucial role of public health organizations in managing public perception during potential outbreaks.
First Piper 